Add to Bookshelf  |  E-mail

Choose format: Standard  |  Short  |  MARC

Title   Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate /
Format   online resource
Internet Access   https://purl.fdlp.gov/GPO/gpo139201  
Author   LinkUnited States. Government Accountability Office, author.
Published   [Washington, D.C.] : United States Government Accountability Office, 2020.
 
SuDoc Number   LinkGA 1.5/2:GAO-20-626 T
Item Number   Link0546-D-01 (online)
Description   1 online resource (26 pages) :  color illustrations, color maps.
Content Type   text
Series   Link(Testimony ; GAO-2-626T.)
General Note   "For release on delivery, expected at 2:30 p.m. ET, Tuesday, June 2, 2020."
Bibliography   Includes bibliographical references.
Metadata Source   Description based on online resource, PDF version; title from cover (GAO, viewed Jun. 4, 2020).
Subject   LinkUnited States. Food and Drug Administration -- Rules and practice.
Subject - LC   LinkCOVID-19 (Disease) -- Treatment -- United States.
  LinkDrugs -- Inspection -- United States.
  LinkDrugs -- United States -- Safety measures -- Evaluation.
  LinkPharmaceutical industry -- Quality control -- Evaluation.
  LinkDrugs -- Safety regulations -- United States -- Evaluation.
  LinkDrug reimportation -- United States -- Evaluation.
  LinkImports -- United States -- Safety measures -- Evaluation.
Added Entry   LinkDenigan-Macauley, Mary, author.
Added Entry   LinkUnited States. Congress. Senate. Committee on Finance, sponsoring body.
URL   Address at time of PURL creation  https://www.gao.gov/assets/710/707345.pdf  
 
Holdings   All items
 
OCLC Number   (OCoLC)1156966114
CGP Record Link   https://catalog.gpo.gov:443/F/?func=direct&doc_number=001122850&local_base=GPO01PUB
System Number   001122850


End Session - Preferences - Feedback - Help - Browse - Search - Results List - Previous Searches - Catalogs to Search - Bookshelf